Earnings · China A-shares
Tibet Duo Rui Pharmaceutical Co., Ltd. Class A (301075) earnings
Tibet Duo Rui Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit +110.74% year on year, +48.76% excluding one-off items. Wave Radar's earnings-quality score is 82 of 100 (Sound). The stock moved -9.74% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- +110.74%
- Excl. one-offs YoY
- +48.76%
- Net profit QoQ
- -111.64%
- Result
- Great
- Quality score
- 82
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -5.62% | — |
| 3 days | -9.74% | — |
| 7 days | -9.89% | — |
| 14 days | -17.69% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 4 of 7 reports (average -0.37%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | ¥8.56M | +110.74% | +48.76% | +8.77% | 0.11 | 1.43% | -9.74% | — | — |
| 2026 interim report | 2026-08-26 | ¥11.53M | +127.13% | +26.54% | -10.24% | 0.15 | 1.90% | +0.51% | +2.18% | +9.17% |
| 2026 Q1 report | 2026-04-29 | -¥13.97M | +10.45% | +15.06% | -34.41% | -0.18 | -2.46% | +1.23% | -18.23% | -19.17% |
| 2025 annual report | 2026-04-29 | -¥102.17M | -63.04% | -61.08% | -35.93% | -1.29 | -16.33% | +1.23% | -18.23% | -19.17% |
| 2025 Q3 report | 2025-10-24 | -¥79.73M | -27.23% | — | -43.07% | -1.01 | -12.95% | +2.94% | -12.69% | -12.46% |
| 2025 interim report | 2025-08-27 | -¥42.50M | -1197.26% | — | -29.13% | -0.54 | -5.86% | +8.58% | +9.78% | +6.00% |
| 2025 Q1 report | 2025-04-25 | -¥15.60M | -514.76% | — | -36.98% | -0.20 | -2.33% | -5.93% | +26.86% | +23.61% |
| 2024 annual report | 2025-04-18 | -¥62.67M | -432.44% | — | -28.02% | -0.79 | -8.71% | -0.18% | +36.10% | +33.20% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.